papillary thyroid cancer glp 1 Frontiers Glucagon-like-peptide-1 receptor expression in normal

The Crossroad of GLP-1 and Cellular Senescence Ageing is a time-dynamic process, typically manifested by degeneration of tissue and organ structure and function, cell damage accumulation, dysfunction of cellular organelles and increased susceptibility to diseases [184]

( 10.1016/S0140-6736(1832261-X) [DOI] [PubMed] [Google Scholar] Hirata K, Kume S, Araki S, Sakaguchi M, Chin-Kanasaki M, Isshiki K, Sugimoto T, Nishiyama A, Koya D, Haneda M, et al

Our data reveal that the replacement of the tryptophan cage (trp-cage) of Exendin-4 tyrosine substituted at the amino terminus (ex-4Y1) with the C terminal undecapeptide sequence of Oxyntomodulin places the lysine 30 of the novel hybrid agonist in frame with the corresponding lysine residue in the native GIP sequence thereby converting the incretin to a GLP-1R-GIPR dual agonist

[2] The active ingredient, semaglutide, mimics the action of the naturally occurring hormone GLP-1, which is released from the intestine in response to food intake